Yu-Xiao Yang, MD, MSCE
Sees patients age 18 and up
Penn Medicine Provider

About me

  • Associate Professor of Medicine (Gastroenterology)
  • Associate Professor of Epidemiology in Biostatistics and Epidemiology

Education and training

  • Medical School: New York University Medical Center
  • Residency: University of Pennsylvania Health System
  • Fellowship: University of Pennsylvania Health System

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Yang is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Wang L, Tate J, Skanderson M, Hauser R, Brandt C, Yang YX, Justice A. Leveraging the Electronic Health Record for Early Detection of Pancreatic Cancer among 9.4 million US Veterans , Clin Transl Gastroenterol: 2026


Peerless Y, Strauss G, Margalit O, Shacham-Shmueli E, Yang YX, Boursi B. The effect of metformin exposure on colorectal cancer incidence according to tumor sidedness , Cancer Epidemiol: 2026


Levinson RN, Bushman R, Tate JP, Skanderson M, Mezzacappa C, Park LS, Brandt CA, Schuster KM, Ketwaroo GA, Yang YX, Justice AC, Wang LL. Pancreatic Ductal Adenocarcinoma After Hepatitis C Infection , JAMA Netw Open, 8: 2025,e2543701


Khan AN, Jones RB Jr, Khan N, Yang YX, Adler RA. Trends in hip fracture rates in US male veterans. , Osteoporos Int., 35(12): 2024,2137-2144


Kanwal F, Kramer JR, Li L, Yang YX, Cao Y, Yu X, Samuel R, Ali B, Desiderio R, Cholankeril G, Bajaj M, El-Serag HB, Asch SM. GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. , JAMA Intern Med., 184(1): 2024,1314-1323


Brown TJ, Gimotty PA, Mamtani R, Karasic TB, Yang YX. Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab. , JCO Clin Cancer Inform, 8: 2024,e2300220


Tobi M, Pascua M, Rodriguez R, Yang YX, Lieb J, Weinstein D, Kaplan DE Prospective Visual Inspection of the Ventrum of Tongue (VIVOT) Vasculature Predicts the Presence of Esophageal Varices , Gastrointest Disord, 6(1): 2024,230-240


Wang L, Rahimi Larki N, Dobkin J, Salgado S, Ahmad N, Kaplan DE, Yang W, Yang YX. A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With Acute Pancreatitis , Pancreas, 53(3): 2024,e254-e259


Mezzacappa C, Larki NR, Skanderson M, Park LS, Brandt C, Hauser RG, Justice A, Yang YX, Wang L. Development and Validation of Case-Finding Algorithms to Identify Pancreatic Cancer in the Veterans Health Administration , Dig Dis Sci, 69(4): 2024,1507-1513


Kurlander JE, Laine L, Kim HM, Roberts CB, Saffar D, Myers A, Holleman R, Gao Y, Shank M, Nelson R, Forman J, Helfrich CD, Krein SL, Saini SD, Yang YX Impact of large scale, multicomponent intervention to reduce proton pump inhibitor overuse in integrated healthcare system: difference-in-difference study , BMJ, 385: 2024,e076484


View all publications